Clinical Trial Update: Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease [Phase 2]

View source ↗

Summary

Phase 2 study of the combination of clofarabine and cytarabine in adults with acute myeloid leukemia across various cytogenetic subtypes and remission states; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia in Remission
• Acute Myeloid Leukemia with
• Acute Myeloid Leukemia with 11q23 Abnormalities
• Acute Myeloid Leukemia with Inv

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clofarabine (clofarabine)

Snippet

Sponsor: University of Washington | Conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 2 | Status: TERMINATED | Results posted: 2017-05-15